Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation

The transcription factor pancreatic and duodenal homeobox factor 1 (PDX-1) is expressed in pancreatic progenitor cells. In exocrine pancreas, PDX-1 is down-regulated during late development, while re-up-regulation of PDX-1 has been reported in pancreatic cancer and pancreatitis. To determine whether...

Full description

Saved in:
Bibliographic Details
Published inGenes & development Vol. 20; no. 11; pp. 1435 - 1440
Main Authors Miyatsuka, Takeshi, Kaneto, Hideaki, Shiraiwa, Toshihiko, Matsuoka, Taka-aki, Yamamoto, Kaoru, Kato, Ken, Nakamura, Yumiko, Akira, Shizuo, Takeda, Kiyoshi, Kajimoto, Yoshitaka, Yamasaki, Yoshimitsu, Sandgren, Eric P, Kawaguchi, Yoshiya, Wright, Christopher V E, Fujitani, Yoshio
Format Journal Article
LanguageEnglish
Published United States Cold Spring Harbor Laboratory Press 01.06.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The transcription factor pancreatic and duodenal homeobox factor 1 (PDX-1) is expressed in pancreatic progenitor cells. In exocrine pancreas, PDX-1 is down-regulated during late development, while re-up-regulation of PDX-1 has been reported in pancreatic cancer and pancreatitis. To determine whether sustained expression of PDX-1 could affect pancreas development, PDX-1 was constitutively expressed in all pancreatic lineages by transgenic approaches. The transgenic pancreas was markedly small with the replacement of acinar cells by duct-like structures, accompanied by activated Stat3. Genetic ablation of Stat3 in the transgenic pancreas profoundly suppressed the metaplastic phenotype. These results provide a mechanism of pancreatic metaplasia by which persistent PDX-1 expression cell-autonomously induces acinar-to-ductal transition through Stat3 activation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Corresponding authors.
E-MAIL yoshio-f@osb.att.ne.jp; FAX 81-3-38135996.
E-MAIL miyatuka@medone.med.osaka-u.ac.jp; FAX 81-6-68793639.
ISSN:0890-9369
1549-5477
DOI:10.1101/gad.1412806